Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Adherens Junctions01:24

Adherens Junctions

Strong contact points between adjacent cells anchor them to each other, forming tissues. Such anchoring junctions are of two types –  adherens junctions and desmosomes. Adherens junctions are abundant in tissues such as  epithelium and endothelium, forming a continuous zone of adhesion called the adhesion belt. In other tissues, such as  heart muscle, they appear as clusters, linking the cells to produce coordinated heart muscle contraction.
Adherens Junctions are Dynamic
The endothelial cells...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of myelopoiesis by <i>Candida dubliniensis</i> drives protective trained immunity against sepsis in a Card9-dependent manner.

mBio·2025
Same author

Type 1 conventional dendritic cells regulate innate immunity during fungal pneumonia.

mBio·2025
Same author

Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammation.

Cell host & microbe·2025
Same author

Comparison Between Two Divergent Diets, Mediterranean and Western, on Gut Microbiota and Cognitive Function in Young Sprague Dawley Rats.

Gut microbes reports·2025
Same author

CD209d/e promotes inflammation and lung injury during influenza virus infection.

ImmunoHorizons·2025
Same author

Sex-specific regulatory architecture of pancreatic islets from subjects with and without type 2 diabetes.

The EMBO journal·2024

Related Experiment Video

Updated: May 9, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Dectin immunoadhesins and pneumocystis pneumonia.

David M Ricks1, Kong Chen, Mingquan Zheng

  • 1Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

Infection and Immunity
|July 10, 2013
PubMed
Summary

Researchers developed novel immunoadhesins targeting Pneumocystis jirovecii

Area of Science:

  • Mycology
  • Immunology
  • Pharmacology

Background:

  • Pneumocystis jirovecii is an opportunistic pathogen causing severe disease in immunocompromised individuals.
  • Immune reconstitution inflammatory syndrome (IRIS) can arise during recovery from immunosuppression, complicating Pneumocystis infections.
  • The fungal cell wall component β-(1,3)-glucan is a target for immune modulation and antifungal strategies.

Purpose of the Study:

  • To develop and characterize novel immunoadhesins targeting β-(1,3)-glucan for potential therapeutic applications against Pneumocystis.
  • To evaluate the in vitro and in vivo efficacy of Dectin-1:Fc immunoadhesins in targeting Pneumocystis and modulating inflammatory responses.

Main Methods:

  • Development of immunoadhesins by fusing the Dectin-1 carbohydrate binding domain to murine IgG (mIgG) Fc regions.

More Related Videos

Isolation of Mouse Lung Dendritic Cells
09:04

Isolation of Mouse Lung Dendritic Cells

Published on: November 22, 2011

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Experiment Videos

Last Updated: May 9, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Isolation of Mouse Lung Dendritic Cells
09:04

Isolation of Mouse Lung Dendritic Cells

Published on: November 22, 2011

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

  • In vitro assays to assess β-glucan binding affinity, cytokine production inhibition, and P. murina viability.
  • In vivo studies using a murine model of Pneumocystis infection and IRIS to evaluate therapeutic effects.
  • Main Results:

    • Dectin-1:Fc immunoadhesins demonstrated high-affinity binding to β-glucan and specificity for Pneumocystis asci.
    • Dectin-1:mIgG2a Fc reduced P. murina viability via complement-dependent mechanisms.
    • Dectin-1:mIgG1 Fc reduced fungal burden in vivo and ameliorated hypoxemia in an IRIS model.

    Conclusions:

    • Targeting β-glucan with Dectin-1:Fc immunoadhesins offers a promising strategy for treating Pneumocystis infections.
    • These engineered molecules can modulate the immune response, potentially mitigating IRIS complications.
    • Fc subtype variation influences the effector functions, suggesting tailored therapeutic approaches.